Dermpath and Clinic: How to manage adverse reactions to biological agents

Eur J Dermatol. 2021 Jun 1;31(3):426-427. doi: 10.1684/ejd.2021.4070.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anaphylaxis / chemically induced*
  • Anaphylaxis / prevention & control*
  • Anti-Asthmatic Agents / adverse effects
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biological Factors / adverse effects*
  • Biological Factors / therapeutic use*
  • Desensitization, Immunologic*
  • Edema / chemically induced
  • Female
  • Humans
  • Omalizumab / adverse effects
  • Urticaria / chemically induced

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Biological Factors
  • Omalizumab
  • dupilumab
  • mepolizumab